K-numberK250591
Device nameAnovo Surgical System (6Ne)
ApplicantMomentis Surgical , Ltd.
Product codeQNM
Device classClass II
Decision dateJun 6, 2025
DecisionSubstantially Equivalent
Regulation878.4961
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Anovo Surgical System (6Ne) is an endoscopic instrument control system that assists physicians in accurately controlling robotic instrument arms during single-site, transvaginal benign laparoscopic-assisted surgical procedures such as hysterectomy, salpingectomy, oophorectomy, and ovarian cyst removal. The surgeon operates from a console outside the sterile field, viewing the surgical site through a standard laparoscopic camera and manipulating instrument controllers.

Technological characteristics

The Anovo Surgical System 6Ne incorporates software updates and console hardware modifications to support optional integration of an off-the-shelf FDA-cleared endoscope arm (SOLOASSIST II by AKTORmed) for camera control, replacing manual manipulation by surgical staff. The annotation feature was removed and replaced with an endoscope control pedal. The system RCU, instruments, and other accessories remain unchanged from the predicate device.

Test standards cited

IEC 60601-1 (basic safety and essential performance), IEC 60601-1-6 (usability), IEC 80601-2-77 (robotically assisted surgical equipment), IEC 60601-1-2 (electromagnetic disturbances), IEC 60601-4-2 (electromagnetic immunity), IEC 60601-2-2 (high-frequency surgical equipment), ISO/IEC 62366-1:2015 (usability engineering), and IEC 62304 (software development).

Substantial equivalence argument

The subject device shares the same intended use and indications as the predicate (K242157). The modifications (endoscope arm support, annotation removal, software/hardware updates) do not raise different safety or effectiveness questions because they are limited to console interface changes that enable optional accessory integration. Non-clinical testing (bench, software, cybersecurity, electrical safety, human factors, and cadaver studies) demonstrated safe and effective operation, with all use-related risks acceptable and no additional risks identified compared to the predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →